Sinha Rajeshwari, Shukla Pratyoosh
Independent Researcher, New Delhi, India.
Enzyme Technology and Protein Bioinformatics Laboratory, Department of Microbiology, Maharshi Dayanand University, Rohtak-124001, Haryana, India.
Protein Pept Lett. 2019;26(2):79-87. doi: 10.2174/0929866525666181026160852.
With the unprecedented rise of drug-resistant pathogens, particularly antibiotic-resistant bacteria, and no new antibiotics in the pipeline over the last three decades, the issue of antimicrobial resistance has emerged as a critical public health threat. Antimicrobial Peptides (AMP) have garnered interest as a viable solution to this grave issue and are being explored for their potential antimicrobial applications. Given their low bioavailability in nature, tailoring new AMPs or strategizing approaches for increasing the yield of AMPs, therefore, becomes pertinent. The present review focuses on biotechnological interventions directed towards enhanced AMP synthesis and revisits existing genetic engineering and synthetic biology strategies for production of AMPs. This review further underscores the importance and potential applications of advanced gene editing technologies for the synthesis of novel AMPs in future.
随着耐药性病原体尤其是耐抗生素细菌的空前增加,且在过去三十年中没有新的抗生素进入研发阶段,抗菌药物耐药性问题已成为严重的公共卫生威胁。抗菌肽(AMP)作为解决这一严重问题的可行方案受到关注,人们正在探索其潜在的抗菌应用。鉴于其在自然界中的低生物利用度,因此定制新的抗菌肽或制定提高抗菌肽产量的策略变得至关重要。本综述聚焦于旨在增强抗菌肽合成的生物技术干预措施,并回顾了用于生产抗菌肽的现有基因工程和合成生物学策略。本综述进一步强调了先进基因编辑技术在未来合成新型抗菌肽方面的重要性和潜在应用。